过去一年中添加的文章,按日期排序

[HTML][HTML] … of targeting miRNA in rheumatic diseases: A computational approach to identify miRNA association with cell types, cytokines, and disease mechanisms

FS Shaikh, RJ Siegel, A Srivastava, DA Fox… - Frontiers in …, 2024 - frontiersin.org
187 天前 - … miR-155 may represent a therapeutic target to safely control fibrosis in systemic …
publications in SLE, with a total of 62. Co-occurrences of miR-146 and various cytokines were …

Preclinical Specificity and Activity of CABA-201, a Fully Human 41BB Containing CD19 CAR T Therapy for Treatment-Resistant Autoimmune Disease

J Weinthal, J Peng, A Alvarado, H Cassim… - … and Cellular Therapy, 2024 - Elsevier
189 天前 - … Targeted biologic therapies directed at cytokine pathways, costimulatory … therapies,
in treatment refractory AD patients, including 8 with systemic lupus erythematosus (SLE), 3 …

Delineation of the molecular basis of sexual dimorphism in autoimmunity

D Kosmara - 2023 - didaktorika.gr
198 天前 - … analysis in SLE patients … SLE patient monocytes as well as in monocytes cultured
under lupus-inducing conditions. To address the role of SMC1A/cohesin in the context of SLE, …

Targeted therapies for lupus nephritis: Current perspectives and future directions

X Jia, Y Lu, X Zheng, R Tang, W Chen - Chinese Medical Journal, 2024 - mednexus.org
199 天前 - … production of type I IFNs and proinflammatory cytokines. Conversely, impaired immune
tolerance … of SLE and LN onset, potential therapeutic targets, and targeted therapy under …

[HTML][HTML] Concurrent remission of lymphoma and Sjögren's disease following anti-CD19 chimeric antigen receptor-T cell therapy for diffuse large B-cell lymphoma: a …

L Sheng, Y Zhang, Q Song, X Jiang, W Cao… - Frontiers in …, 2023 - frontiersin.org
200 天前 - … -T cell therapy has been reported in rheumatoid arthritis and systemic lupus
erythematosus; … of cytokines from day 0 to day 90 after CAR-T cell therapy assessed using a …

Molecular-Targeted Drugs in Rheumatology

E Tanaka - Tokyo Women's Medical University Journal, 2023 - jstage.jst.go.jp
201 天前 - … Cell-surface antigens, cytokines, receptors, and signal … elucidated, and therapeutic
targets have been identified. … diseases, including systemic lupus erythematosus, systemic …

CD19-targeted CAR-T cells in refractory systemic autoimmune diseases: a monocentric experience from the first fifteen patients

F Mueller, J Taubmann, S Voelkl, L Bucci, C Bergmann… - Blood, 2023 - Elsevier
208 天前 - target autoreactive B cells that trigger autoimmune diseases (AID) including systemic
lupus erythematosus (SLE… T Cell therapy in AID was very favourable with cytokine-release …

Symposium 11: Treating Infection with Immunosuppression—An Emerging Spectrum of Autoimmunity

J WONG - Journal of Clinical Rheumatology and Immunology, 2023 - World Scientific
212 天前 - … (rheumatoid arthritis, systemic lupus erythematosus or immune mediated myositis)
are … diseases which target the host’s own immune system (or associated cytokines) are …

[PDF][PDF] BAFF AND RHEUMATIC AUTOIMMUNE DISORDERS: IMPLICATIONS FOR DISEASE MANAGEMENT AND THERAPY

C DARIDON, A SARAUX, GP FERRACCIOLP - academia.edu
220 天前 - … ofdiseases include systemic lupus erythematosus (SLE), … Targeting B-cells may
even become a therapeutic target … production of BAFF and related cytokines in SLE, RA, SS and …

[HTML][HTML] Immunology and Osteoporosis: A New Frontier in Treatment

R Mukherjee, CM Chang… - … , Management and Therapy, 2023 - intechopen.com
229 天前 - … cells, related cytokines, and their functions. Long-term inflammation, immune
cell production of RANKL, and autoimmune illnesses like systemic lupus erythematosus and …